The Lab–Phenotype Mismatch Problem

Prev
 1 / 21 
Next
Prev
 1 / 21 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • interpret discordance between VWF laboratory results and bleeding phenotype
  • distinguish evidence for VWD from evidence for a clinically important bleeding disorder
  • apply a probabilistic framework to VWD diagnosis
  • recognize pitfalls of privileging either laboratory values or bleeding symptoms alone
  • explain why VWF levels may change over time or across physiologic states
  • identify when discordance should prompt repeat testing or diagnostic expansion
  • compare low VWF, type 1 VWD-spectrum biology, and alternative bleeding disorders

A patient has VWF antigen 27 IU/dL, VWF activity 25 IU/dL, minimal bleeding symptoms, and no history of procedural bleeding. What is the best interpretation?

a
This patient definitely has clinically severe VWD
A is incorrect because low VWF levels do not automatically imply clinically severe disease. Bleeding phenotype and hemostatic challenge history still matter.
b
The low VWF values provide strong laboratory evidence of VWF-spectrum biology, but clinical severity remains uncertain
The correct answer is correct because VWF levels below 30 IU/dL provide strong evidence for VWF-linked disease biology or VWD-spectrum pathology. However, the absence of significant bleeding or hemostatic challenges limits confidence about the patient’s clinical bleeding risk.
c
The absence of bleeding excludes VWD
C is incorrect because absence of bleeding does not exclude VWD, especially if the patient has not faced major hemostatic challenges.
d
No further evaluation is needed because the phenotype is quiet
D is incorrect because discordance should prompt careful context review, repeat testing when appropriate, and assessment of family history and procedural history.

A patient has VWF antigen 62 IU/dL and VWF activity 58 IU/dL, but reports heavy menstrual bleeding since menarche and postpartum hemorrhage. What is the most appropriate conclusion?

a
Classic type 1 VWD is established
A is incorrect because type 1 VWD is not established by this laboratory pattern.
b
Clinically important bleeding is unlikely because VWF is above 50 IU/dL
B is incorrect because near-normal VWF does not exclude clinically important bleeding or another bleeding disorder.
c
The bleeding history is important, but the available VWF results weaken a classic VWD diagnosis
The correct answer is correct because a serious bleeding phenotype deserves evaluation, but VWF levels above 50 IU/dL do not by themselves support classic type 1 VWD. Repeat testing, activity-to-antigen relationships, FVIII, family history, and alternative diagnoses should be considered.
d
The patient should be labeled as VWD based on symptoms alone
D is incorrect because symptoms alone should not create a lifelong VWD diagnosis without supportive laboratory or contextual evidence.

What is the central diagnostic lesson of lab–phenotype mismatch in VWD?

a
Laboratory values should override bleeding history
A is incorrect because laboratory values are important but incomplete. They measure surrogates, not in vivo bleeding risk.
b
Bleeding history should override laboratory values
B is incorrect because bleeding symptoms are also incomplete. Common bleeding symptoms may occur in people without VWD.
c
VWD cannot be diagnosed unless all three domains are perfectly concordant
C is incorrect because perfect concordance is not always present. Discordance changes probability; it does not automatically invalidate the diagnosis.
d
Diagnosis depends on convergence among phenotype, laboratory pattern, and inheritance or context
D is correct because VWD diagnosis is probabilistic. Bleeding phenotype, laboratory pattern, and inheritance or context each shift diagnostic confidence.

In which setting is a BAT most useful as an initial screening tool to decide whether specialized VWD testing is needed?

a
A primary care patient with vague bruising and low pretest probability
BATs are most useful in low-pretest-probability settings, where they can standardize the history and help decide whether VWF-specific testing is warranted.
b
A child with an affected parent who has confirmed VWD
B is high pretest probability because of the affected first-degree relative. A BAT should not be used alone to avoid testing.
c
A hematology referral with recurrent procedure-related bleeding
C is already an intermediate or high concern setting. The BAT can document bleeding severity but should not gate evaluation.
d
A patient with VWF activity repeatedly below 30 IU/dL
D already has a strong laboratory signal. The BAT helps phenotype the patient but does not decide whether the abnormality exists.

Why is the 30–50 IU/dL VWF range diagnostically challenging?

a
VWF assays are invalid in this range
A is incorrect because assays are not invalid, but interpretation is more difficult.
b
Most patients in this range have type 3 VWD
B is incorrect because type 3 VWD is characterized by virtual absence of VWF, not values in the 30–50 IU/dL range.
c
This range often overlaps with physiologic variation, modifier effects, and common bleeding symptoms
The correct answer is C because VWF levels in the 30–50 IU/dL range occupy a gray zone. They may reflect low VWF, mild type 1 VWD-spectrum biology, physiologic variation, blood group effects, modifier genes, or coincidence with common bleeding symptoms.
d
Bleeding risk is always absent in this range
D is incorrect because some patients in this range have clinically important bleeding, especially when bleeding is reproducible and objectively corroborated.

Which scenario best illustrates the danger of privileging the laboratory result?

a
A patient with severe heavy menstrual bleeding is dismissed because VWF is 58 IU/dL
A is correct because dismissing a serious bleeding phenotype solely because VWF is near normal is a classic lab-privileging error. The patient may not have classic VWD, but the bleeding still deserves evaluation.
b
A patient with VWF activity 22 IU/dL is evaluated further despite no bleeding
B is incorrect because further evaluation of very low VWF is reasonable.
c
A patient with borderline VWF and no bleeding is not labeled with VWD
C is incorrect because avoiding premature labeling in a minimally symptomatic patient is appropriate caution.
d
A patient with abnormal VWF testing has repeat testing performed
D is incorrect because repeat testing is good practice when diagnosis is uncertain or results are discordant.

Which scenario best illustrates the danger of privileging the phenotype?

a
A patient with VWF 24 IU/dL and no bleeding is recognized as having uncertain clinical severity
A is incorrect because this interpretation appropriately separates laboratory evidence from clinical severity.
b
A patient with postpartum hemorrhage and normal VWF is evaluated for other bleeding disorders
B is incorrect because severe bleeding with normal VWF should prompt diagnostic expansion, not dismissal.
c
A patient with easy bruising, VWF 44 IU/dL, blood group O, no family history, and no hemostatic challenges is labeled with lifelong VWD after one test
The correct answer is correct because common bleeding symptoms plus a borderline VWF value can lead to overdiagnosis if interpreted without context, repeat testing, family history, or hemostatic challenge history.
d
A patient with low VWF has testing repeated on a separate occasion
D is incorrect because repeat testing reduces uncertainty.

A patient diagnosed with type 1 VWD in adolescence now has VWF antigen 68 IU/dL at age 55. What is the best interpretation?

a
The prior diagnosis must be erased
A is incorrect because normalization over time does not automatically erase prior VWD biology or bleeding phenotype.
b
The current normal value alone does not settle the diagnosis
The correct answer is correct because VWF levels may rise with age, inflammation, pregnancy, and other physiologic states. Reassessment should consider the original diagnosis, bleeding history, repeat testing, hemostatic challenges, and consequences of changing the label.
c
The patient now has type 3 VWD
C is incorrect because type 3 VWD involves virtual absence of VWF.
d
Bleeding risk is impossible to assess
D is incorrect because bleeding risk can be assessed probabilistically using phenotype, history, labs, and treatment response.

Which factor can move a patient across a VWF diagnostic threshold without necessarily changing the underlying bleeding story?

a
Blood group
The correct answer is correct because blood group, especially group O, influences VWF levels. Other modifiers include pregnancy, inflammation, aging, stress, exercise, estrogen exposure, and thyroid status.
b
Eye color
B is incorrect because eye color is not a recognized modifier of VWF levels.
c
Serum sodium
C is incorrect because serum sodium does not explain VWF threshold crossing in this context.
d
Platelet count alone
D is incorrect because platelet count may matter in some bleeding evaluations, but it does not by itself explain VWF level fluctuation across diagnostic thresholds.

What is the best reason to repeat VWF testing in a discordant case?

a
VWF testing is never reliable
A is incorrect because VWF testing is useful, but must be interpreted carefully.
b
Repeat testing guarantees a definitive diagnosis
B is incorrect because repeat testing improves confidence but does not guarantee certainty.
c
Repeat testing replaces the bleeding history
C is incorrect because laboratory testing and bleeding history remain complementary.
d
VWF levels may fluctuate and preanalytical or physiologic factors can distort interpretation
The correct answer is correct because VWF is biologically variable and assay results may be affected by physiologic state, sample handling, and timing. Repeat testing helps establish whether the laboratory pattern is stable.

Why can family normalization make BAT interpretation difficult?

a
Families with VWD always exaggerate bleeding symptoms
A is an unsupported generalization.
b
Family history is irrelevant once a BAT is obtained
C is wrong because family history changes pretest probability.
c
BATs automatically correct for family culture
D overstates what structured questionnaires can do.
d
Similar bleeding in relatives may be dismissed as normal because “everyone bleeds that way”
A family may normalize heavy menses, epistaxis, bruising, or procedural bleeding because multiple relatives share similar symptoms. This can lower reported concern despite a real inherited bleeding tendency.

In a Bayesian approach to VWD diagnosis, what does mismatch do?

a
It automatically rules out VWD
A is incorrect because mismatch does not automatically rule out VWD.
b
It automatically confirms VWD
A is incorrect because mismatch does not automatically rule out VWD.
c
It recalibrates probability
The correct answer is correct because discordance changes the probability of VWD or another bleeding disorder. It should lead to reweighing the evidence rather than automatic acceptance or rejection.
d
It makes further evaluation unnecessary
D is incorrect because mismatch often increases the need for repeat testing, context review, and diagnostic expansion.

Which statement best captures the clinical synthesis of this spoke?

a
The laboratory number is the diagnosis
A is incorrect because VWF values are important but incomplete.
b
The bleeding story is the diagnosis
B is incorrect because bleeding symptoms require interpretation and may have causes other than VWD.
c
Diagnostic confidence emerges from convergence over time
The correct answer is correct because the core lesson is that VWD diagnosis becomes more secure when bleeding phenotype, laboratory pattern, and inheritance or context move in the same direction over time.
d
Diagnostic uncertainty means no treatment should be offered
D is incorrect because uncertainty does not always mean inaction. It may justify treatment planning, repeat testing, or broader evaluation.

Sort each item into the domain it most directly informs during evaluation of lab–phenotype mismatch in VWD.

First-degree relative with confirmed VWD
Postpartum hemorrhage
FVIII activity
Recurrent dental extraction bleeding
Blood group O
Repeat VWF antigen 24 IU/dL
VWF activity-to-antigen ratio
Pregnancy at time of testing
Iron deficiency from heavy menstrual bleeding
Bleeding phenotype
Laboratory pattern
Inheritance/context

Match each discordant pattern with the best reasoning response.

VWF antigen 62 IU/dL, severe heavy menstrual bleeding and postpartum hemorrhage
Prior type 1 VWD diagnosis, current VWF antigen 70 IU/dL at older age
VWF antigen 26 IU/dL, minimal bleeding
Strong laboratory evidence of VWF-spectrum biology, but clinical severity remains uncertain
Clinically important bleeding is present, but classic VWD is weakened unless additional VWF evidence emerges
Longitudinal mismatch; reassess using prior diagnosis, bleeding history, repeat testing, age, and hemostatic challenges
Correct! Sorry, Incorrect.

Closing Note

The lab–phenotype mismatch is not a nuisance at the edge of VWD diagnosis.

It is the diagnostic work itself.

Expert reasoning does not choose the number over the story, or the story over the number. It lets the signals converge, notices when they do not, and resists closure until probability has been given time to clarify.

Prev
 1 / 21 
Next